Empagliflozin is a type of medicinal drug used to treat kind 2 diabetes by means of decreasing blood sugar levels. It belongs to a type of pills referred to as SGLT2 inhibitors, which work by means of decreasing glucose reabsorption in the kidneys and growing urinary glucose excretion. Some studies have suggested that empagliflozin may have extra benefits, such as lowering the hazard of coronary heart disorder and stroke.